Get started
Author

Kieran P. Jefferson

Observed names: Jefferson, Kieran, K Jefferson, K. Jefferson, K. P. Jefferson, K.P Jefferson, K.P. JEFFERSON, K.P. Jefferson, Kieran Jefferson, Kieran P Jefferson
Observed institutions: Royal United Hospital, Southmead Hospital, University Hospital Coventry, University Hospitals Coventry and Warwickshire NHS Trust, Bristol Royal Infirmary, University of Bristol, Cancer Research UK Clinical Trials Unit, University of Birmingham
ORCID: 0000-0002-0029-8359
Observed ORCID: 0000-0002-0029-8359
OpenAlex ID: A5076914970
Introduction of an enhanced recovery protocol for radical cystectomy
2008 · Nimalan Arumainayagam, John McGrath, et al. · British Journal of Urology · 190
Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study
2021 · Richard T. Bryan, Wenyu Liu, et al. · European Urology · 63
PDF
'Special K' and a Loss of Cell-To-Cell Adhesion in Proximal Tubule-Derived Epithelial Cells: Modulation of the Adherens Junction Complex by Ketamine
2013 · Claire E. Hills, Tianrong Jin, et al. · PLoS ONE · 38
PDF
Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression
2023 · Richard T. Bryan, Sarah J. Pirrie, et al. · JAMA Network Open · 30
PDF
Serum Amino-Terminal Propeptide of Type 1 Procollagen (P1NP) in Prostate Cancer: A Potential Predictor of Bone Metastases and Prognosticator for Disease Progression and Survival
2006 · R. Thurairaja, R.K. Iles, et al. · Urologia Internationalis · 26
Thoracic Kidney:: a Rare Form of Renal Ectopia
2001 · K.P. JEFFERSON, R.A. PERSAD · The Journal of Urology · 25
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial
2025 · Richard T. Bryan, Wenyu Liu, et al. · Journal of Clinical Oncology · 16
Erratum: Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial
2025 · Richard T. Bryan, Wenyu Liu, et al. · Journal of Clinical Oncology · 15
Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: A systematic review and evidence of a potential mechanism
2019 · Janet A. Dunn, Kieran Jefferson, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 15
Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection
2023 · L. Baxter, N. S. Gordon, et al. · Scientific Reports · 12
PDF
Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma
2001 · K. Jefferson, R. Persad · British Journal of Urology · 11
The 10 000 hour rule
2009 · D. MacDonald, K. Jefferson · BMJ · 10
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT
2024 · Nicholas James, Sarah Pirrie, et al. · Health Technology Assessment · 8
Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action
2023 · Veronica Nanton, Richard T Bryan, et al. · BMJ Oncology · 7
PDF
Leiomyosarcoma of the Cephalic Vein
2001 · Kieran P. Jefferson, John H. Dixon · Sarcoma · 7
PDF
Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient–Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study
2018 · Philip Cornford, Kieran Jefferson, et al. · Oncology and Therapy · 6
PDF
Hereditary urological cancer syndromes
2007 · Kieran P Jefferson, David A Gillatt · Nature Clinical Practice Urology · 6
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5
Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath study.
2020 · Nicholas D. James, Sarah Pirrie, et al. · Journal of Clinical Oncology · 5
LBA111 Randomized comparison of upfront magnetic resonance imaging versus transurethral resection for staging new bladder cancers: Final survival analysis from the BladderPath trial
2025 · N.D. James, S. Pirrie, et al. · Annals of Oncology · 3
PDF
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?
2021 · Richard T. Bryan, James W.F. Catto, et al. · European Urology · 3
Bladder cancer risk is associated with low serum 25-hydroxyvitamin D levels; a systematic review
2016 · Corina Chivu, Janet Dunn, et al. · European Journal of Surgical Oncology · 2
Switching to A 6-Monthly Triptorelin Formulation for Prostate Cancer (Pca) Reduces Patient–Nhs Interactions and Hospital Resource use: Real World Evidence (Rwe) from Project Deserve (Decapeptyl Service Evaluation)
2015 · P Cornford, K Jefferson, et al. · Value in Health · 2
PDF
Apoptosis and its relevance to urologists
2000 · K.P. Jefferson, R.A. Persad, et al. · British Journal of Urology · 2
An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial
2026 · Liam Bourke, Derek J Rosario, et al. · The Lancet Oncology · 1
Works count: 45
Citation count: 528
H-index: 11
I10-index: 13
Year
Topic
Type